Ward Ferry Management (Bvi) LTD I Mab Transaction History

Ward Ferry Management (Bvi) LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$57.18 - $84.43 $102 Million - $151 Million	-1,791,496 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$44.38 - $63.97 $46.1 Million - $66.4 Million	1,038,559 Added 137.93%	1,791,496 $86.8 Million
Q4 2020 Feb 08, 2021	BUY	$32.94 - $47.15 $24.8 Million - $35.5 Million	752,937 New	752,937 $35.5 Million

16.8M

14.5K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $69M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Ward Ferry Management (Bvi) LTD, based on Form 13F filings with the SEC.

Stay updated on Ward Ferry Management (Bvi) LTD with notifications on news.